What is Castle Biosciences's net investment gains (losses)?

Castle Biosciences (CSTL) reported net investment gains (losses) of $2.02M in Q1 2026.

How has Castle Biosciences's net investment gains (losses) changed year-over-year?

Castle Biosciences's net investment gains (losses) increased by 241.9% year-over-year, from -$1.43M to $2.02M.

What does net investment gains (losses) mean?

Net realized and unrealized gains and losses on the company's investment portfolio, including equity securities, debt securities, and alternative investments.

Castle Biosciences CSTL Net investment gains (losses)

Net investment gains (losses) at other companies

Main Street CapitalMAIN

$17.97M+161%

Peoples Financial ServicesPFIS

$456K+542%

Liberty GlobalLBTYB

$132.2M+180%

CNB FinancialCCNE

$331K—

Unusual MachinesUMAC

$7.26M—

RepligenRGEN

$0—

Segments

By segment

See full

Reportable Segment$1.47M+164%

Other financials

Income statement

See full

Revenue$83.7M-4.9%

Gross profit$63.1M-11.8%

Operating income-$18.4M+34.1%

Net income-$14.5M+43.8%

EPS (diluted)-$0.49+45.6%

Balance sheet

See full

Cash & equivalents$63.8M-28.9%

Total debt$36.7M+42.1%

Total equity$461.4M+4.8%

Total assets$547.8M+9.2%

Cash flow

See full

Operating cash flow-$22.1M-267%

CapEx$12.5M+163%

Free cash flow-$34.6M-221%

Valuation

See full

Market cap$694.86M+29.9%

Enterprise value$667.82M+41.8%

P/S2×+0.5×

Profitability

See full

Gross margin77.9%-4.1pp

Operating margin-9.8%-30.8pp

Net margin-3.8%-10.2pp

FCF margin1.3%-10.7pp

Returns & leverage

See full

Return on equity-2.8%-10.6pp

Debt / equity0.1×0.0×

Current ratio6.7×-2.6×

Where this comes from

Reported directly by Castle Biosciences in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesFvNiGainLoss.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's net investment gains (losses).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Castle Biosciences's net investment gains (losses)?: Castle Biosciences (CSTL) reported net investment gains (losses) of $2.02M in Q1 2026.
How has Castle Biosciences's net investment gains (losses) changed year-over-year?: Castle Biosciences's net investment gains (losses) increased by 241.9% year-over-year, from -$1.43M to $2.02M.
What does net investment gains (losses) mean?: Net realized and unrealized gains and losses on the company's investment portfolio, including equity securities, debt securities, and alternative investments.